{"filing":{"accession_number":"0001104659-26-109329","cik":"0000812796","ticker":"SNGX","company_name":"SOLIGENIX, INC.","form":"8-K","filing_date":"2026-09-21","report_date":"2026-09-17","primary_document":"sngx-20260917x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/812796/000110465926109329/sngx-20260917x8k.htm"},"events":[{"id":34034,"run_id":31331,"accession_number":"0001104659-26-109329","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Soligenix held its Annual Meeting of Stockholders on September 17, 2026, with all seven proposals approved: election of five directors, approval of a reverse stock split (1-for-2 to 1-for-20 ratio at board discretion), increase in authorized shares from 75 million to 125 million, advisory vote on executive compensation, frequency of future advisory votes, ratification of Cherry Bekaert LLP as independent auditors, and meeting adjournment.","company_name":"SOLIGENIX, INC.","ticker":"SNGX","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":[{"id":37654,"accession_number":"0001104659-26-109329","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure reports a routine amendment to the Certificate of Incorporation increasing authorized shares from 75 million to 125 million, approved by stockholders at the 2026 annual meeting and filed with Delaware on September 17, 2026. While a governance matter, the increase in authorized shares is a standard administrative action that does not materially affect the registrant's financial condition, operations, or investor risk profile absent evidence of imminent dilutive issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:38:02.114248+00:00","company_name":"","ticker":null,"filing_date":""},{"id":37655,"accession_number":"0001104659-26-109329","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the complete results of Soligenix's Annual Meeting of Stockholders held on September 17, 2026, including voting outcomes on seven proposals: election of five directors, approval of a reverse stock split (1-for-2 to 1-for-20 ratio at board discretion), increase in authorized shares from 75M to 125M, advisory vote on executive compensation, frequency of future advisory votes, ratification of Cherry Bekaert LLP as independent auditors, and meeting adjournment. All proposals passed. The reverse stock split and authorized shares increase are material corporate actions requiring shareholder approval, making the vote results material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:38:02.114248+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":34035,"run_id":31331,"accession_number":"0001104659-26-109329","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Soligenix increased the maximum aggregate offering amount under its At Market Issuance Sales Agreement (ATM offering) by an additional $2,500,000 of common stock, with approximately $6,234,000 already sold under prior prospectus supplements.","company_name":"SOLIGENIX, INC.","ticker":"SNGX","filing_date":"2026-09-21","form":"8-K","submitted_at":null,"items":[{"id":37656,"accession_number":"0001104659-26-109329","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an increase to the maximum aggregate offering amount under an At Market Issuance Sales Agreement (ATM offering) by an additional $2,500,000 of common stock. The company has already sold approximately $6,234,000 under prior prospectus supplements. ATM offerings are equity issuances that dilute existing shareholders and are a material capital-raising mechanism, particularly for smaller companies like Soligenix.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:38:02.114248+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37654,"accession_number":"0001104659-26-109329","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure reports a routine amendment to the Certificate of Incorporation increasing authorized shares from 75 million to 125 million, approved by stockholders at the 2026 annual meeting and filed with Delaware on September 17, 2026. While a governance matter, the increase in authorized shares is a standard administrative action that does not materially affect the registrant's financial condition, operations, or investor risk profile absent evidence of imminent dilutive issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:38:02.114248+00:00","company_name":"SOLIGENIX, INC.","ticker":"SNGX","filing_date":"2026-09-21"},{"id":37655,"accession_number":"0001104659-26-109329","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the complete results of Soligenix's Annual Meeting of Stockholders held on September 17, 2026, including voting outcomes on seven proposals: election of five directors, approval of a reverse stock split (1-for-2 to 1-for-20 ratio at board discretion), increase in authorized shares from 75M to 125M, advisory vote on executive compensation, frequency of future advisory votes, ratification of Cherry Bekaert LLP as independent auditors, and meeting adjournment. All proposals passed. The reverse stock split and authorized shares increase are material corporate actions requiring shareholder approval, making the vote results material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:38:02.114248+00:00","company_name":"SOLIGENIX, INC.","ticker":"SNGX","filing_date":"2026-09-21"},{"id":37656,"accession_number":"0001104659-26-109329","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The filing discloses an increase to the maximum aggregate offering amount under an At Market Issuance Sales Agreement (ATM offering) by an additional $2,500,000 of common stock. The company has already sold approximately $6,234,000 under prior prospectus supplements. ATM offerings are equity issuances that dilute existing shareholders and are a material capital-raising mechanism, particularly for smaller companies like Soligenix.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-21T20:38:02.114248+00:00","company_name":"SOLIGENIX, INC.","ticker":"SNGX","filing_date":"2026-09-21"}]}